Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Weighted Average) (2019 - 2025)

Legend Biotech filings provide 7 years of Shares Outstanding (Weighted Average) readings, the most recent being $100.0 billion for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 20833333233.33% to $100.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $100.0 billion, a 20833333233.33% increase, with the full-year FY2025 number at $100.0 billion, up 27244.66% from a year prior.
  • Shares Outstanding (Weighted Average) hit $100.0 billion in Q4 2025 for Legend Biotech, up from $37.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $100.0 billion in Q4 2025 to a low of $210.0 in Q2 2024.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $36.5 million (2023), compared with a mean of $5.6 billion.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 100.0% in 2024 and later surged 20833333233.33% in 2025.
  • Legend Biotech's Shares Outstanding (Weighted Average) stood at $281.7 million in 2021, then increased by 12.91% to $318.1 million in 2022, then tumbled by 99.99% to $36000.0 in 2023, then crashed by 98.67% to $480.0 in 2024, then surged by 20833333233.33% to $100.0 billion in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $100.0 billion (Q4 2025), $37.0 million (Q3 2025), and $37.0 million (Q2 2025) per Business Quant data.